BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

MAKO MEDICAL LABORATORIES

via LINCHPIN STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 20, 2021Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: MAKO MEDICAL LABORATORIES
Description: Laboratory Services
Location: North Carolina · United States of America

Registrant

Firm: LINCHPIN STRATEGIES, LLC
Description: Government Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Funding for COVID testing, genomic sequencing, and other COVID-related issues; updates to public health infrastructure.
LobbyistsCATRIONA MACDONALD
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MAKO MEDICAL LABORATORIES — Lobbying — Receipts Report